The Company's principal activity is researching, developing and commercialising anti-infective pharmaceutical medicines for the treatment of serious human infectious diseases. It focuses on the discovery of innovative medicines for the treatment of the diseases caused by Human Immunodeficiency Virus (HIV) and Vancomycin- and methicillin-resistant bacteria. It operates in Australia.
Alacra Alerts:
Receive alerts on the latest reports on Avexa Ltd.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
